MHA Today is provided as a service to members of the Missouri Hospital Association. Additional information is available online at MHAnet.
In This Issue
Legislators To Negotiate Prescription Drug Bill Differences
State House Sends Bills To Senate
HIDI HealthStats — Opioid Mortality Research
CDC Releases Recommendations For Diagnosing And Managing Shigella Strains
CDC Launches Opioid Webinar Series
state and federal health policy developments
Staff Contact: Daniel Landon
The state House of Representatives has refused to accept the Senate’s changes to House Bill 90, which would authorize the creation of a state prescription drug monitoring program. A legislative conference committee will attempt to negotiate a resolution to the differences between the House and Senate versions of the bill. The product of those negotiations then must be ratified by each chamber.
Back To Top
Staff Contacts: Daniel Landon or Rob Monsees
Yesterday, the state House of Representatives gave its final approval to several health-related bills. They now move to the Senate.
HIDI Tech Connect
Staff Contact: Mat Reidhead
The May edition of HIDI HealthStats explores drug-related deaths among middle-aged, white Missourians. Geographically, since 2000, the highest rates of drug-induced overdose deaths in Missouri have occurred in St. Louis City, Greene County and the region stretching from Jefferson County through the lead-belt and into Pemiscot and Dunklin counties in the Bootheel (Figure 3). The map was created by pooling data from 2000 to 2015 because of the Centers for Disease Control and Prevention’s data suppression rules; however, other studies suggest significant recent problems with opioid abuse in the state’s most populous region — St. Louis County. Additionally, CDC data indicate the three most populous counties in the state with data available in 1999 and 2015 — St. Louis, Jackson and St. Louis City — had significant increases in the drug overdose death rate at 193, 168 and 171 percent, respectively.
Back To Top
Quality and Population Health
Staff Contact: Jackie Gatz
The Centers for Disease Control and Prevention has released recommendations for diagnosing and managing Shigella strains with possible reduced susceptibility to ciprofloxacin. The health advisory outlines new recommendations for clinical diagnosis, managing and reporting, as well as recommendations for laboratories and public health officials. The Missouri Department of Health and Senior Services also released a supplemental advisory on the topic. Shigellosis is a nationally notifiable condition, and all cases of shigellosis should be reported to local health departments. Contact DHSS’ Bureau of Communicable Disease Control and Prevention at 573/751-6113 for more information.
Back To Top
Staff Contact: Leslie Porth
The Centers for Disease Control and Prevention has launched a new online training series based on the 2016 opioid prescribing guidelines for adults with chronic pain. The free web-based training helps providers understand and apply the guidelines for adult patients with chronic pain. The first module presents an overview of the guidelines.
Back To Top
Rates of new diagnosed cases of Type 1 and Type 2 diabetes are on the rise in young children and teens. Between 2002 and 2012, the rate of new diagnosed cases of Type 1 diabetes in youth increased by about 1.8 percent each year, while Type 2 diabetes increased even more quickly at 4.8 percent.
Source: The New England Journal of Medicine